 |
 |
 |
|
Salvage Therapy in Cancer Patients with Hepatitis C without
Sustained VirologicResponse after Direct-Acting Antivirals -A Prospective Study
|
|
|
AASLD 2019 Nov 8-11 Boston
Reported by Jules Levin
Haley Pritchard,1, 2*DeekshaJandhyala,2*Georgios Angelidakis,2Jeff Hosry,2and Harrys A. Torres2,3
1Department of Infectious Disease, Baylor College of Medicine, Houston, Texas; 2Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas; 3Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.
*Dr. Pritchard's current affiliation is the Department of Infectious Diseases, University of Indiana School of Medicine. Dr. Jandhyala'scurrent affiliation is the Department of Medicine, Medical University of South Carolina



|
|
|
 |
 |
|
|